The activation of HMGB1 as a progression factor on inflammation response in normal human bronchial epithelial cells through RAGE/JNK/NF-κB pathway

[1]  Yi Luo,et al.  High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. , 2013, European journal of cancer.

[2]  X. Jia,et al.  Amelioration of compound 4,4'-diphenylmethane-bis(methyl)carbamate on high mobility group box1-mediated inflammation and oxidant stress responses in human umbilical vein endothelial cells via RAGE/ERK1/2/NF-κB pathway. , 2013, International immunopharmacology.

[3]  Yan Chen,et al.  Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance , 2013, Cancer Immunology, Immunotherapy.

[4]  A. M. Houghton.  Endogenous modifiers of cigarette smoke exposure within the lung. , 2012, Proceedings of the American Thoracic Society.

[5]  S. Szala,et al.  [HMGB1--its role in tumor progression and anticancer therapy]. , 2012, Postepy higieny i medycyny doswiadczalnej.

[6]  John D Lambris,et al.  Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression , 2012, The Journal of Immunology.

[7]  Hai Qian,et al.  Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239. , 2012, Oncology letters.

[8]  J. A. Nogueira-Machado,et al.  HMGB-1 as a target for inflammation controlling. , 2012, Recent patents on endocrine, metabolic & immune drug discovery.

[9]  E. Wattenberg,et al.  Inhibition of mitogen activated protein kinases increases the sensitivity of A549 lung cancer cells to the cytotoxicity induced by a kava chalcone analog. , 2012, Biochemical and biophysical research communications.

[10]  M. Shafi,et al.  Attenuation of Aβ-induced neurotoxicity by thymoquinone via inhibition of mitochondrial dysfunction and oxidative stress , 2012, Molecular and Cellular Biochemistry.

[11]  G. Delsol,et al.  ALK+ALCLs induce cutaneous, HMGB-1-dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation. , 2012, Blood.

[12]  P. Chanvorachote,et al.  Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. , 2012, International journal of physiology, pathophysiology and pharmacology.

[13]  K. Sabapathy.  Role of the JNK pathway in human diseases. , 2012, Progress in molecular biology and translational science.

[14]  M. Fujimoto,et al.  Tumorigenesis and Neoplastic Progression Host-Derived MCP-1 and MIP-1 Regulate Protective Anti-Tumor Immunity to Localized and Metastatic B 16 Melanoma , 2011 .

[15]  M. Bucova,et al.  HMGB1 and its physiological and pathological roles. , 2012, Bratislavske lekarske listy.

[16]  Wende Li,et al.  Genistein Inhibit Cytokines or Growth Factor-Induced Proliferation and Transformation Phenotype in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis , 2012, Inflammation.

[17]  Youhua Xu,et al.  Phytoestrogen calycosin‐7‐O‐β‐D‐glucopyranoside ameliorates advanced glycation end products‐induced HUVEC damage , 2011, Journal of cellular biochemistry.

[18]  W. Zin,et al.  Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice , 2011, Respiratory Physiology & Neurobiology.

[19]  B. Rothen‐Rutishauser,et al.  Cytotoxicity and genotoxicity of size-fractionated iron oxide (magnetite) in A549 human lung epithelial cells: role of ROS, JNK, and NF-κB. , 2011, Chemical research in toxicology.

[20]  Jing Wang,et al.  [Expression of high mobility group box chromosomal protein 1 in mice with lupus nephritis]. , 2011, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.

[21]  Yongwei Yao,et al.  Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK. , 2011, American journal of physiology. Heart and circulatory physiology.

[22]  June Choi,et al.  Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line. , 2011, Tumori.

[23]  Yi Luo,et al.  Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer , 2011, Expert opinion on therapeutic targets.

[24]  N. Wu,et al.  Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. , 2011, Neoplasma.

[25]  L. Yang,et al.  Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China. , 2015, Genetics and molecular research : GMR.

[26]  A. Józkowicz,et al.  Oxidative stress in tumor angiogenesis- therapeutic targets. , 2010, Current pharmaceutical design.

[27]  B. Mittal,et al.  Oxidative stress in non‐small cell lung cancer patients after chemotherapy: Association with treatment response , 2010, Respirology.

[28]  P. Leung,et al.  Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-κB signalling pathways in human pancreatic adenocarcinoma cells , 2010, British Journal of Cancer.

[29]  T. Arumugam,et al.  RAGE and RAGE ligands in cancer. , 2007, Current molecular medicine.

[30]  W. Parrish,et al.  HMGB-1 AS A THERAPEUTIC TARGET FOR INFECTIOUS AND INFLAMMATORY DISORDERS , 2006, Shock.

[31]  U. Heinrich,et al.  Role of inflammation in chemical-induced lung cancer. , 2000, Toxicology letters.